Revolution Medicines (RVMD) Competitors $40.38 -0.29 (-0.71%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RVMD vs. BNTX, ONC, SMMT, TEVA, ITCI, GMAB, RDY, ASND, MRNA, and VTRSShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include BioNTech (BNTX), Beigene (ONC), Summit Therapeutics (SMMT), Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Moderna (MRNA), and Viatris (VTRS). These companies are all part of the "pharmaceutical products" industry. Revolution Medicines vs. BioNTech Beigene Summit Therapeutics Teva Pharmaceutical Industries Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Ascendis Pharma A/S Moderna Viatris BioNTech (NASDAQ:BNTX) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation. Does the MarketBeat Community favor BNTX or RVMD? BioNTech received 47 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 77.17% of users gave Revolution Medicines an outperform vote while only 46.93% of users gave BioNTech an outperform vote. CompanyUnderperformOutperformBioNTechOutperform Votes14546.93% Underperform Votes16453.07% Revolution MedicinesOutperform Votes9877.17% Underperform Votes2922.83% Does the media refer more to BNTX or RVMD? In the previous week, Revolution Medicines had 3 more articles in the media than BioNTech. MarketBeat recorded 23 mentions for Revolution Medicines and 20 mentions for BioNTech. Revolution Medicines' average media sentiment score of 1.35 beat BioNTech's score of 0.93 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioNTech 10 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 16 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in BNTX or RVMD? 15.5% of BioNTech shares are owned by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are owned by institutional investors. 19.2% of BioNTech shares are owned by insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable valuation and earnings, BNTX or RVMD? BioNTech has higher revenue and earnings than Revolution Medicines. BioNTech is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNTech$2.75B9.08$1.01B-$3.00-34.72Revolution Medicines$742K10,117.48-$436.37M-$3.57-11.31 Which has more volatility and risk, BNTX or RVMD? BioNTech has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Do analysts rate BNTX or RVMD? BioNTech currently has a consensus price target of $143.44, suggesting a potential upside of 37.72%. Revolution Medicines has a consensus price target of $66.67, suggesting a potential upside of 65.10%. Given Revolution Medicines' stronger consensus rating and higher possible upside, analysts clearly believe Revolution Medicines is more favorable than BioNTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioNTech 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.89Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BNTX or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to BioNTech's net margin of -15.16%. BioNTech's return on equity of -2.35% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BioNTech-15.16% -2.35% -2.05% Revolution Medicines N/A -33.67%-30.08% SummaryRevolution Medicines beats BioNTech on 10 of the 19 factors compared between the two stocks. Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMD vs. The Competition Export to ExcelMetricRevolution MedicinesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.51B$3.00B$5.56B$7.83BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-11.2530.4222.4418.48Price / Sales10,117.48498.92393.95103.59Price / CashN/A168.6838.1834.62Price / Book3.643.206.774.25Net Income-$436.37M-$72.35M$3.22B$248.23M7 Day Performance4.67%1.46%1.45%0.89%1 Month Performance20.11%8.79%3.96%3.53%1 Year Performance4.02%-22.36%16.07%5.08% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVMDRevolution Medicines3.7636 of 5 stars$40.38-0.7%$66.67+65.1%+8.3%$7.51B$742,000.00-11.25250Upcoming EarningsAnalyst ForecastPositive NewsBNTXBioNTech2.546 of 5 stars$101.81+3.1%$143.44+40.9%+17.3%$24.43B$2.75B-48.483,080Upcoming EarningsONCBeigene2.0222 of 5 stars$229.22-0.8%$316.71+38.2%N/A$22.66B$3.81B-27.829,000Analyst ForecastAnalyst RevisionSMMTSummit Therapeutics2.6688 of 5 stars$25.22+2.5%$35.40+40.4%+513.7%$18.60B$700,000.00-90.07110Analyst ForecastPositive NewsTEVATeva Pharmaceutical Industries3.237 of 5 stars$13.30-2.6%$23.43+76.2%+10.5%$15.08B$16.54B-9.1736,800Upcoming EarningsAnalyst RevisionPositive NewsITCIIntra-Cellular Therapies0.8841 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560Upcoming EarningsAnalyst ForecastGMABGenmab A/S4.4508 of 5 stars$20.07+0.1%$39.17+95.2%-23.6%$13.28B$21.53B11.531,660Upcoming EarningsAnalyst RevisionRDYDr. Reddy's Laboratories1.8436 of 5 stars$13.68+0.1%$17.00+24.3%-5.3%$11.42B$311.31B21.7824,800Upcoming EarningsASNDAscendis Pharma A/S2.3244 of 5 stars$161.15-2.4%$204.67+27.0%+23.1%$9.83B$363.64M-22.70640Positive NewsMRNAModerna4.3453 of 5 stars$25.13+1.7%$58.70+133.6%-74.1%$9.72B$3.20B-2.713,900VTRSViatris1.8335 of 5 stars$7.57+0.1%$10.50+38.7%-27.2%$9.04B$14.74B-10.2337,000Upcoming Earnings Related Companies and Tools Related Companies BNTX Alternatives ONC Alternatives SMMT Alternatives TEVA Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives ASND Alternatives MRNA Alternatives VTRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RVMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVMD Stock Free RVMD Stock Alerts